Medable, a leader in clinical development technology, has partnered with Google Cloud to offer its Digital and Decentralized Clinical Trial Platform on the Google Cloud Marketplace. This collaboration aims to streamline access and procurement for life sciences companies, enabling them to leverage Google Cloud’s advanced infrastructure and artificial intelligence (AI) capabilities to enhance clinical trial design, execution, and data management.
Transforming Clinical Trials with Cloud Technology
By integrating Medable’s platform with Google Cloud, life sciences companies gain access to cutting-edge tools that streamline trial design, execution, and data management. Medable’s platform will now include Studio, a software-as-a-service (SaaS) solution designed to enhance clinical trial organization. With Studio, pharmaceutical and clinical research organizations can benefit from greater transparency, improved workflows, and more efficient management of decentralized clinical trials.
Medable’s co-founder and CEO, Michelle Longmire, highlighted the significance of this partnership, stating:
“This alliance provides life sciences companies with Medable’s cutting-edge clinical development technology powered by Google Cloud through Google Cloud Marketplace. The collaboration will enable scaled and seamless adoption of Medable solutions by Google Cloud users, providing life sciences companies with platform capabilities proven to improve patient access to trials and accelerate critical development efforts globally.”
Simplifying Procurement and Billing
The integration with Google Cloud Marketplace introduces a streamlined procurement process for Medable users. Customers can now pay for Medable’s services directly through Google Cloud invoices, with the added flexibility of applying a portion of their committed Google Cloud spend toward Medable services. This consolidated billing system eliminates administrative hurdles, making it easier for companies to adopt the platform at scale.
A Proven Track Record of Success
This announcement follows Medable’s ongoing efforts to revolutionize clinical trials. Over the past year, Medable collaborated with the Multi-Regional Clinical Trials Center of Brigham and Women’s Hospital and Harvard (MRCT Center) to release a toolkit for ethical reviews in decentralized clinical trials (DCTs). The company has already deployed its SaaS platform in over 300 decentralized and hybrid clinical trials across 60 countries, involving nearly one million patients globally.
Medable reports that its solutions have consistently delivered significant benefits, including:
- 200% faster patient enrollment
- 50% cost reductions in trial operations
The Future of Clinical Trials
Medable’s partnership with Google Cloud represents a pivotal step in the digital transformation of clinical trials. By combining Medable’s expertise with Google’s robust infrastructure and AI capabilities, this alliance promises to accelerate the development of critical therapies and expand patient access to innovative trials on a global scale.
